Skip to main content

Markets Collapse As Vaccine Subject Gets Ill

AstraZeneca (AZN​​​​​​​) - a leader in the race to find a coronavirus vaccine - stopped its trial after one of the test subject's fell ill in a potential adverse reaction to the company's experimental COVID-19 vaccine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.